Evidence map›Paper›PMID 41383818›Full record

ArticleFrontiers in aging neuroscience2025

Absence of the

Vinod Metta, Anjana Soorajkumar, Tom Loney, Nasna Nassir, K Ray Chaudhuri, Mohammed Jashim Uddin, Hani T S Benamer

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in aging neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Vinod Metta *Department of Neurosciences, King's College London, Institute of Psychiatry, Psychology & Neuroscience, London, United Kingdom.
Anjana Soorajkumar *Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, New York, NY, United States.
Tom LoneyDepartment of Basic Sciences, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Dubai, United Arab Emirates.
Nasna NassirCenter for Applied and Translational Genomics (CATG), Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Dubai, United Arab Emirates.
K Ray ChaudhuriParkinson's Foundation Centre of Excellence, King's College Hospital, London, United Kingdom.
Mohammed Jashim UddinDepartment of Basic Sciences, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Dubai, United Arab Emirates.
Hani T S BenamerDepartment of Clinical Sciences, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Dubai, United Arab Emirates.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The role of genetic factors in the pathogenesis of Parkinson's disease (PD) is characterized by heterogeneity in specific genetic variations and their prevalence across different populations and geographic locations. Objective: To investigate the frequency of the Leucine-rich repeat kinase 2 ( Methods: Emirati PD patients were recruited from the United Arab Emirates between September 2022 and May 2024. Blood samples were systematically screened for mutations across all 52 exons of the Results: The Conclusion: The absence of the

Indexed as

Emirati populationepidemiologygeneticleucine-rich repeat kinase 2 (LRRK2)Parkinson’s disease (PD)

Identifiers

PMID41383818
PMCPMC12689503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.